Moderna Inc.’s stock slid 5% Friday, after the COVID vaccine maker said a trial of a flu-vaccine candidate failed to meet one of its goals.
You are here: Home / Top Stories / Coronavirus Update: Moderna’s stock hit as flu-vaccine trial fails on one target. Meanwhile, China declares victory over COVID.